152 related articles for article (PubMed ID: 25332143)
1. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
Levenson AS; Kumar A; Zhang X
Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
[TBL] [Abstract][Full Text] [Related]
2. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
[TBL] [Abstract][Full Text] [Related]
3. MTA1 drives malignant progression and bone metastasis in prostate cancer.
Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
[TBL] [Abstract][Full Text] [Related]
5. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
6. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
[TBL] [Abstract][Full Text] [Related]
7. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
8. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
Kai L; Wang J; Ivanovic M; Chung YT; Laskin WB; Schulze-Hoepfner F; Mirochnik Y; Satcher RL; Levenson AS
Prostate; 2011 Feb; 71(3):268-80. PubMed ID: 20717904
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.
Ganju A; Chauhan SC; Hafeez BB; Doxtater K; Tripathi MK; Zafar N; Yallapu MM; Kumar R; Jaggi M
Br J Cancer; 2018 Feb; 118(4):587-599. PubMed ID: 29465084
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of MTA proteins in normal and cancer cells.
Liu J; Wang H; Huang C; Qian H
Cancer Metastasis Rev; 2014 Dec; 33(4):843-56. PubMed ID: 25398252
[TBL] [Abstract][Full Text] [Related]
11. Metastasis-Associated 1 (MTA1) Gene Expression Promotes Angiogenesis in Mouse Xenografts from Human Non-Small Cell Lung Cancer (NSCLC) Cells.
Wang T; Li W; Huang H; Wang C
Med Sci Monit; 2019 Jan; 25():484-491. PubMed ID: 30651530
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of MTA proteins in human cancer.
Kaur E; Gupta S; Dutt S
Cancer Metastasis Rev; 2014 Dec; 33(4):1017-24. PubMed ID: 25374266
[TBL] [Abstract][Full Text] [Related]
13. Properties and clinical relevance of MTA1 protein in human cancer.
Toh Y; Nicolson GL
Cancer Metastasis Rev; 2014 Dec; 33(4):891-900. PubMed ID: 25359582
[TBL] [Abstract][Full Text] [Related]
14. Role of MTA1 in cancer progression and metastasis.
Sen N; Gui B; Kumar R
Cancer Metastasis Rev; 2014 Dec; 33(4):879-89. PubMed ID: 25344802
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
[TBL] [Abstract][Full Text] [Related]
17. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.
Sheridan CM; Grogan TR; Nguyen HG; Galet C; Rettig MB; Hsieh AC; Ruggero D
Oncotarget; 2015 Apr; 6(10):7470-80. PubMed ID: 25797255
[TBL] [Abstract][Full Text] [Related]
18. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.
Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS
FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399
[TBL] [Abstract][Full Text] [Related]
19. MTA1 expression in human cancers - Clinical and pharmacological significance.
Malisetty VL; Penugurti V; Panta P; Chitta SK; Manavathi B
Biomed Pharmacother; 2017 Nov; 95():956-964. PubMed ID: 28915537
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
Levenson AS
Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
